Its dual-receptor mechanism provides a valuable framework for studying coordinated pathway activation, receptor-mediated communication, and downstream biological responses within controlled experimental environments
"I still have things about my body that I dont like," Adele revealed
Less than 0.01% of mental health customers sought more comprehensive care due to adverse events
As proof of concept that PCSK9/GLP-1 peptide-antibody molecules can deliver dual pharmacology, we investigated a panel of N-terminal genetic fusions of a DPP-4-resistant GLP-1 analogue with different PCSK9 antibodies and linkers
Competitive Landscape of Obesity GLP-1 Market The global GLP-1 and obesity drug landscape is entering a transformative phase as patent protections for semaglutide near expiry in key markets such as India and China by 2026
Dadkhah M, Baziar M, Rezaei N